In vivo mouse models to study bile acid synthesis and signaling.

[1]  G. Guo,et al.  FXR and NASH: an avenue for tissue-specific regulation. , 2023, Hepatology communications.

[2]  M. Hayden,et al.  Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans , 2022, The Journal of clinical investigation.

[3]  Changtao Jiang,et al.  Intestinal hypoxia-inducible factor 2α regulates lactate levels to shape the gut microbiome and alter thermogenesis. , 2021, Cell metabolism.

[4]  K. Matsuki,et al.  Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments , 2021, Journal of atherosclerosis and thrombosis.

[5]  Changtao Jiang,et al.  DCA-TGR5 signaling activation alleviates inflammatory response and improves cardiac function in myocardial infarction. , 2020, Journal of molecular and cellular cardiology.

[6]  Satoru Takahashi,et al.  Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition[S] , 2019, Journal of Lipid Research.

[7]  J. C. Wolters,et al.  A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice[S] , 2019, Journal of Lipid Research.

[8]  B. Buckley,et al.  Bile Acid Homeostasis in a Cholesterol 7α‐Hydroxylase and Sterol 27‐Hydroxylase Double Knockout Mouse Model , 2019, Hepatology.

[9]  H. Nittono,et al.  Complete Recovery of Oxysterol 7α-Hydroxylase Deficiency by Living Donor Transplantation in a 4-Month-Old Infant: the First Korean Case Report and Literature Review , 2018, Journal of Korean medical science.

[10]  M. Hayden,et al.  Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition. , 2018, American journal of physiology. Endocrinology and metabolism.

[11]  Yi-horng Lee,et al.  The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. , 2017, Molecular aspects of medicine.

[12]  J. Chiang,et al.  Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders[S] , 2016, Journal of Lipid Research.

[13]  Runping Liu,et al.  Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2 , 2014, Hepatology.

[14]  James B. Mitchell,et al.  Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity , 2013, Nature Communications.

[15]  J. Chiang.  Bile acid metabolism and signaling. , 2013, Comprehensive Physiology.

[16]  F. Bäckhed,et al.  Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.

[17]  S. Spiegel,et al.  Conjugated bile acids activate the sphingosine‐1‐phosphate receptor 2 in primary rodent hepatocytes , 2012, Hepatology.

[18]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[19]  G. Tsujimoto,et al.  Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. , 2005, Biochemical and biophysical research communications.

[20]  Sander M Houten,et al.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. , 2004, The Journal of clinical investigation.

[21]  J. Raufman,et al.  Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry. , 2002, European journal of pharmacology.

[22]  M. Haussler,et al.  Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.

[23]  D. Russell,et al.  Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. , 2001, Journal of lipid research.

[24]  R. Evans,et al.  An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Honda,et al.  Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX. , 2001, Journal of lipid research.

[26]  D. Russell,et al.  Disruption of the Sterol 27-Hydroxylase Gene in Mice Results in Hepatomegaly and Hypertriglyceridemia , 2000, The Journal of Biological Chemistry.

[27]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[28]  T. A. Kerr,et al.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.

[29]  D. Russell,et al.  Disruption of the Oxysterol 7α-Hydroxylase Gene in Mice* , 2000, The Journal of Biological Chemistry.

[30]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[31]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[32]  N. Maeda,et al.  Markedly Reduced Bile Acid Synthesis but Maintained Levels of Cholesterol and Vitamin D Metabolites in Mice with Disrupted Sterol 27-Hydroxylase Gene* , 1998, The Journal of Biological Chemistry.

[33]  D. Russell,et al.  Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. , 1996, The Journal of biological chemistry.

[34]  J. Stindt,et al.  Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors. , 2019, Handbook of experimental pharmacology.

[35]  C. Eng,et al.  Human cholesterol 7a-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype , 2018 .

[36]  J. Chiang,et al.  Mechanism of tissue‐specific farnesoid X receptor in suppressing the expression of genes in bile‐acid synthesis in mice , 2012, Hepatology.

[37]  I. Bjorkhem,et al.  A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis. , 1985, Scandinavian journal of clinical and laboratory investigation. Supplementum.